↓ Skip to main content
What is this page? Embed badge

Use of the Peroxisome Proliferator-Activated Receptor (PPAR) γ Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

Overview of attention for article published in Breast Cancer Research and Treatment, June 2003
Altmetric Badge

Mentioned by

patent
8 patents

Citations

dimensions_citation
200 Dimensions

Readers on

mendeley
54 Mendeley
Summary Patents Dimensions citations
So far, Altmetric has seen 8 patents that reference this research output.

This page is provided by Altmetric.